Evidence map›Paper›PMID 30091976›Full record

Trial reportPloS one2018

Diabetes prevalence in rural Indigenous Guatemala: A geographic-randomized cross-sectional analysis of risk.

Kent D W Bream, Amelia Breyre, Kristian Garcia, Erwin Calgua, Juan M Chuc, Lynne Taylor

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Kent D W BreamDepartment of Family Medicine and Community Health, Raymond and Ruth Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.ORCID 0000-0002-5592-3625
Amelia BreyreCenter for Global Health, Raymond and Ruth Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Kristian GarciaHarnwell College House, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Erwin CalguaHarnwell College House, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Juan M ChucHospitalito Atitlán, Canton Ch'utch'aj, Santiago Atitlán, Sololá, Guatemala.
Lynne TaylorCenter of Excellence for Diversity in Health Education and Research, Raymond and Ruth Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Universidad de San Carlos de Guatemala · GTCenter for Global Health · USOffice of Diversity and Inclusion · USUniversity of Pennsylvania · US

Funding

Chronic disease clinical epidemiology training in guatemala and peruD43TW008317 · FIC · UNIVERSITY OF PENNSYLVANIA · PI BRANAS, CHARLES C. · 2010 to 2014
$1.1M
FIC NIH HHS D43 TW008317
6 · The paper itself

Abstract

backgroundDeveloping countries and Indigenous populations are disproportionately affected by global trends in diabetes (T2DM), but inconsistent data are available to corroborate this pattern in Guatemala and indigenous communities in Central America. Historic estimates of T2DM, using a variety of sampling techniques and diagnostic methods, in Guatemala include a T2DM prevalence of: 4·2% (1970) and 8·4% (2003). Objectives of this geographically randomized, cross-sectional analysis of risk include: (1) use HbA1c to determine prevalence of T2DM and prediabetes in rural Indigenous community of Atitlán (2) identify risk factors for T2DM including age, BMI and gender.

methodsA spatially random sampling method was used to identify 400 subjects. Prevalence was compared using the confidence interval method, and logistic regression and linear regression were used to assess association between diabetes and risk factors.

findingsThe overall prevalence of T2DM using HbA1c was 13·81% and prediabetes was also 13·81% in Atitlán, representing a tripling in diabetes from historic estimates and a large population with pre-diabetes. The probability of diabetes increased dramatically with increasing age, however no significant overall relationship existed with gender or BMI.

conclusionsDiabetes is a larger epidemic than previously expected and appears to be related to ageing rather than BMI. Our proposed explanations for these findings include: possible Indigenous unique genetic susceptibility to T2DM, shortcomings in BMI as a metric for adiposity in assessing risk, changes in lifestyle and diet, and an overall aging population. The conclusion of this study suggest that (1) T2DM in rural regions of Guatemala may be of epidemic proportion. With pre-diabetes, more than 25% of the population will be diabetic in the very near future; (2) Age is a significant risk factor in the Indigenous population but BMI is not. This suggests that in some populations diabetes may be a disease of ageing.

Indexed as

AdolescentAdultAgedCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGuatemalaHumansMaleMiddle AgedPopulation GroupsPrediabetic StatePrevalenceRisk FactorsRural PopulationYoung Adult

Identifiers

PMID30091976
PMCPMC6084861
OpenAlexW2886818149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.